SIGN UP
LOG IN
This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Benzinga·03/20/2025 13:55:09
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- B. Riley Securities analyst Kalpit Patel initiated coverage on ArriVent BioPharma, Inc. (NASDAQ:AVBP) with a Buy rating and announced a price target of $37. ArriVent BioPharma shares closed at $19.60 on Wednesday. See how other analysts view this stock.
- Goldman Sachs analyst Noah Poponak initiated coverage on Amentum Holdings, Inc. (NYSE:AMTM) with a Neutral rating and announced a price target of $21. Amentum Holdings shares closed at $19.03 on Wednesday. See how other analysts view this stock.
- Morgan Stanley analyst Judah Frommer initiated coverage on Celldex Therapeutics, Inc. (NASDAQ:CLDX) with an Overweight rating and announced a price target of $46. Celldex Therapeutics shares closed at $19.95 on Wednesday. See how other analysts view this stock.
- JP Morgan analyst Detlef Winckelmann initiated coverage on International Paper Company (NYSE:IP) with an Overweight rating and announced a price target of $59. International Paper shares closed at $52.62 on Wednesday. See how other analysts view this stock.
- Scotiabank analyst Patrick Colville initiated coverage on Microsoft Corporation (NASDAQ:MSFT) with a Sector Outperform rating and announced a price target of $470. Microsoft shares closed at $387.82 on Wednesday. See how other analysts view this stock.
Considering buying MSFT stock? Here’s what analysts think:
Read This Next:
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.